Moreover, this HL ‘transformation’ had a distinct somatic mutation profile from the antecedent DLBCL indicating that the HL may have been a second primary malignancy arising out of the same high‐risk CHIP milieu, rather than a true histological transformation from parental DLBCL. The gene discussed is STUB1; the disease is diffuse large B-cell lymphoma.